This article narrates the efforts being made to bring a new spring into the lives of Arab women with breast cancer in the progressive nation of the Sultanate of Oman. It is an inspiration and role model for other nations that treasure the cause of promoting women’s health in the fight against cancer.
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.